LICRX
Price
$15.96
Change
-$0.06 (-0.37%)
Updated
May 8 closing price
Net Assets
372.76M
VTSNX
Price
$138.72
Change
-$0.53 (-0.38%)
Updated
May 8 closing price
Net Assets
469.79B
Ad is loading...

LICRX vs VTSNX

Header iconLICRX vs VTSNX Comparison
Open Charts LICRX vs VTSNXBanner chart's image
Lord Abbett International Equity R3
Price$15.96
Change-$0.06 (-0.37%)
VolumeN/A
Net Assets372.76M
Vanguard Total Intl Stock Index I
Price$138.72
Change-$0.53 (-0.38%)
VolumeN/A
Net Assets469.79B
LICRX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LICRX vs. VTSNX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LICRX is a Buy and VTSNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 470B vs. LICRX (373M). VTSNX pays higher dividends than LICRX: VTSNX (3.04) vs LICRX (1.07). LICRX was incepted earlier than VTSNX: LICRX (18 years) vs VTSNX (14 years). LICRX (1.22) is less costly to investors than VTSNX (0.06). LICRX is a more actively managed with annual turnover of: 89.00 vs. VTSNX (3.00). LICRX has a lower initial minimum investment than VTSNX: LICRX (0) vs VTSNX (5000000). LICRX annual gain was more profitable for investors over the last year : 8.97 vs. VTSNX (7.99). VTSNX (48.76) and LICRX (46.67) have equivalent 5 years return.
LICRXVTSNXLICRX / VTSNX
Total Expense Ratio1.220.062,033%
Annual Report Gross Expense Ratio1.220.062,033%
Fund Existence18 years14 years-
Gain YTD13.29610.014133%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets373M470B0%
Annual Yield % from dividends1.073.0435%
Returns for 1 year8.977.99112%
Returns for 3 years34.7525.84134%
Returns for 5 years46.6748.7696%
Returns for 10 years30.0232.8191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAMVX11.16N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
VSRAX21.12N/A
N/A
Invesco Small Cap Value R
LMGYX29.76N/A
N/A
Lord Abbett Growth Opportunities I
BHCUX17.90N/A
N/A
Baron Health Care R6
FERAX11.11N/A
N/A
First Eagle Global Real Assets A